News summary produced by Claude AI
TrumpRx, a government website launched in February carrying President Trump’s name, was designed to offer discounted prescription medications as part of the administration’s effort to reduce drug prices. The site resulted from an executive order issued in May 2025 aimed at aligning American drug prices with those in other wealthy nations. Following letters sent to 17 pharmaceutical companies the previous summer outlining demands for lower direct-to-consumer pricing, all companies subsequently announced agreements with the Trump administration.
The website currently features 92 brand-name drugs from 15 of the 17 companies that signed agreements, but these offerings represent a limited portion of the companies’ total portfolios. Pfizer leads with 30 drugs on TrumpRx, yet this accounts for only a fraction of its approximately 178 marketed brand-name drugs. Notably absent from the site are several blockbuster medications that generate substantial revenue, including Eliquis, Ibrance, and Paxlovid from Pfizer, as well as Keytruda from Merck. Some companies including Gilead and Regeneron have announced plans to add drugs but have not yet done so.
Health policy experts have noted that pharmaceutical companies are selectively offering discounts on a limited product subset rather than engaging in comprehensive price reductions across their portfolios. Boston University health economist Rena Conti observed that insurers typically provide more affordable options through copays than TrumpRx discounts. The program may benefit patients without insurance coverage or those whose medications lack insurance coverage, though such cases represent a minority of prescription drug users.
Since May, TrumpRx expanded to include generic medications through partnerships with retailers like Cost Plus Drugs and Amazon Pharmacy, dividing the site into “presidential deals” for branded medications and a “standard prices” section for generics. The website claims to have saved over $400 million for Americans, though this statistic remains unverified and has not been updated in more than a month. GoodRx provides the coupon infrastructure enabling TrumpRx discounts to function within the existing pharmacy system, with early data indicating concentrated demand for GLP-1 therapies.